Charts Abbott Laboratories Börse Stuttgart
Stocks
ABL
US0028241000
Medical Equipment, Supplies & Distribution
|
Market Closed -
Börse Stuttgart
03:46:07 28/08/2026 HKT
|
5-day change | 1st Jan Change | ||
| 95.64 EUR | -2.43% |
|
+0.18% | -7.05% |
| 08-28 | Abbott Laboratories Insider Sold Shares Worth $46,204,798, According to a Recent SEC Filing | MT |
| 08-27 | Abbott Laboratories' Stroke Treatment Device Receives CE Mark | MT |
Chart: Technical Analysis
Stock exchange
Börse Stuttgart
ABL 95.64 €
-2.43%
6.69K
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
NYSE
| ABT | 111.59USD | -2.20% | 932M $ | |
CBOE
| ABT | 111.56USD | -2.21% | 31.74M $ | |
Tradegate
| ABL | 95.78EUR | -2.19% | 157K € | |
London S.E.
| ABT | 112.75USD | -2.28% | 90.99K $ | |
Xetra
| ABL | 96.16EUR | -2.57% | 51.93K € | |
Boerse Muenchen
| ABL | 95.66EUR | -2.55% | 41.23K € | |
CBOE
| 96.98EUR | -2.41% | 12.22K € | ||
Börse Stuttgart
| ABL | 95.64EUR | -2.43% | 6.69K € | |
CBOE
| ABT | 96.24EUR | -2.20% | 4.04K € | |
Mexican S.E.
| ABT * | 1,970.00MXN | 0.00% | 21.67K $ | |
Kazakhstan S.E.
| ABT_KZ | 124.00USD | -1.43% | 620 $ | |
Swiss Exchange
| ABT | 90.50CHF | -2.69% | 0 CHF | |
Lima
| ABTUS | 110.37USD | 0.00% | 0 $ | |
Wiener Boerse
| ABT | 100.10EUR | +0.62% | 0 € | |
Santiago S.E.
| ABT | 110.37USD | 0.00% | 0 $ | |
Santiago S.E.
| ABTCL | 106,710.00CLP | +5.76% | 0 $ | |
Deutsche Boerse AG
| ABL | 97.60EUR | -0.91% | 0 € | |
Borsa Italiana
| 1ABT | 96.22EUR | -2.55% | 0 € | |
Sao Paulo
| ABTT34 | 48.15BRL | -3.22% | 3.76K R$ | |
Buenos Aires S.E.
| ABT | 46,440.00ARS | -0.43% | 147M $ | |
Buenos Aires S.E.
| ABTD | 30.14USD | -0.43% | 4.67K $ | |
Deutsche Boerse AG
| ABL0 | 12.30EUR | -0.81% | 0 € | |
Toronto S.E.
| ABT | 19.52CAD | -2.35% | 190K $ |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ABT Stock
- ABL Stock
- Charts Abbott Laboratories
Select your edition
All financial news and data tailored to specific country editions

















